Activated protein C resistance in young African American patients with ischemic stroke

Seemant Chaturvedi, Nishith Joshi, Jeffery Dzieczkowski

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: It has been proposed that activated protein C resistance (APCR) due to the factor V Leiden (FVL) mutation may be a risk factor for stroke in young adults. However, this may not be the case for all ethnic groups due to variability in the prevalence of the FVL mutation. Methods: Case series from a university neurology clinic. Patients with an APCR ratio of 2.2 or below were tested for the FVL mutation (nine patients). Patients on warfarin were also tested for the FVL mutation (14 patients). Results: 38 African American patients under age 55 with an arterial stroke were identified. The mean age of the patients is 43.1 years. Five percent had an APCR ratio of 2.0 or below. None of the patients with an APCR ratio of 2.2 or below or the patients directly tested for the FVL mutation had the mutant allele. Conclusions: Activated protein C resistance due to the FVL mutation does not appear to be a major risk factor for stroke in young African Americans. Other, as yet unidentified, mechanisms leading to activated protein C resistance may be important in a small subset of young African American stroke patients.

Original languageEnglish (US)
Pages (from-to)137-139
Number of pages3
JournalJournal of the Neurological Sciences
Volume163
Issue number2
DOIs
StatePublished - Mar 1 1999
Externally publishedYes

Fingerprint

Activated Protein C Resistance
African Americans
Stroke
Mutation
Warfarin
Neurology
Ethnic Groups
factor V Leiden
Young Adult
Alleles

Keywords

  • Activated protein C resistance
  • African Americans
  • Cerebral infarction
  • Factor V Leiden
  • Hypercoagulability
  • Young adults

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Activated protein C resistance in young African American patients with ischemic stroke. / Chaturvedi, Seemant; Joshi, Nishith; Dzieczkowski, Jeffery.

In: Journal of the Neurological Sciences, Vol. 163, No. 2, 01.03.1999, p. 137-139.

Research output: Contribution to journalArticle

@article{5729428b24c243ebb5095e7a3e960623,
title = "Activated protein C resistance in young African American patients with ischemic stroke",
abstract = "Background: It has been proposed that activated protein C resistance (APCR) due to the factor V Leiden (FVL) mutation may be a risk factor for stroke in young adults. However, this may not be the case for all ethnic groups due to variability in the prevalence of the FVL mutation. Methods: Case series from a university neurology clinic. Patients with an APCR ratio of 2.2 or below were tested for the FVL mutation (nine patients). Patients on warfarin were also tested for the FVL mutation (14 patients). Results: 38 African American patients under age 55 with an arterial stroke were identified. The mean age of the patients is 43.1 years. Five percent had an APCR ratio of 2.0 or below. None of the patients with an APCR ratio of 2.2 or below or the patients directly tested for the FVL mutation had the mutant allele. Conclusions: Activated protein C resistance due to the FVL mutation does not appear to be a major risk factor for stroke in young African Americans. Other, as yet unidentified, mechanisms leading to activated protein C resistance may be important in a small subset of young African American stroke patients.",
keywords = "Activated protein C resistance, African Americans, Cerebral infarction, Factor V Leiden, Hypercoagulability, Young adults",
author = "Seemant Chaturvedi and Nishith Joshi and Jeffery Dzieczkowski",
year = "1999",
month = "3",
day = "1",
doi = "10.1016/S0022-510X(99)00008-8",
language = "English (US)",
volume = "163",
pages = "137--139",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Activated protein C resistance in young African American patients with ischemic stroke

AU - Chaturvedi, Seemant

AU - Joshi, Nishith

AU - Dzieczkowski, Jeffery

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Background: It has been proposed that activated protein C resistance (APCR) due to the factor V Leiden (FVL) mutation may be a risk factor for stroke in young adults. However, this may not be the case for all ethnic groups due to variability in the prevalence of the FVL mutation. Methods: Case series from a university neurology clinic. Patients with an APCR ratio of 2.2 or below were tested for the FVL mutation (nine patients). Patients on warfarin were also tested for the FVL mutation (14 patients). Results: 38 African American patients under age 55 with an arterial stroke were identified. The mean age of the patients is 43.1 years. Five percent had an APCR ratio of 2.0 or below. None of the patients with an APCR ratio of 2.2 or below or the patients directly tested for the FVL mutation had the mutant allele. Conclusions: Activated protein C resistance due to the FVL mutation does not appear to be a major risk factor for stroke in young African Americans. Other, as yet unidentified, mechanisms leading to activated protein C resistance may be important in a small subset of young African American stroke patients.

AB - Background: It has been proposed that activated protein C resistance (APCR) due to the factor V Leiden (FVL) mutation may be a risk factor for stroke in young adults. However, this may not be the case for all ethnic groups due to variability in the prevalence of the FVL mutation. Methods: Case series from a university neurology clinic. Patients with an APCR ratio of 2.2 or below were tested for the FVL mutation (nine patients). Patients on warfarin were also tested for the FVL mutation (14 patients). Results: 38 African American patients under age 55 with an arterial stroke were identified. The mean age of the patients is 43.1 years. Five percent had an APCR ratio of 2.0 or below. None of the patients with an APCR ratio of 2.2 or below or the patients directly tested for the FVL mutation had the mutant allele. Conclusions: Activated protein C resistance due to the FVL mutation does not appear to be a major risk factor for stroke in young African Americans. Other, as yet unidentified, mechanisms leading to activated protein C resistance may be important in a small subset of young African American stroke patients.

KW - Activated protein C resistance

KW - African Americans

KW - Cerebral infarction

KW - Factor V Leiden

KW - Hypercoagulability

KW - Young adults

UR - http://www.scopus.com/inward/record.url?scp=0033103819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033103819&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(99)00008-8

DO - 10.1016/S0022-510X(99)00008-8

M3 - Article

VL - 163

SP - 137

EP - 139

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -